These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30681179)

  • 1. Anticonvulsant evaluation and docking analysis of VV-Hemorphin-5 analogues.
    Todorov P; Rangelov M; Peneva P; Todorova N; Tchekalarova J
    Drug Dev Res; 2019 Jun; 80(4):425-437. PubMed ID: 30681179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization and anticonvulsant activity of new series of N-modified analogues of VV-hemorphin-5 with aminophosphonate moiety.
    Todorov P; Peneva P; Tchekalarova J; Rangelov M; Georgieva S; Todorova N
    Amino Acids; 2019 Nov; 51(10-12):1527-1545. PubMed ID: 31576456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential anticonvulsant activity of novel VV-hemorphin-7 analogues containing unnatural amino acids: synthesis and characterization.
    Todorov P; Peneva P; Tchekalarova J; Georgieva S
    Amino Acids; 2020 Apr; 52(4):567-585. PubMed ID: 32206933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship study on new hemorphin-4 analogues containing steric restricted amino acids moiety for evaluation of their anticonvulsant activity.
    Todorov P; Peneva P; Tchekalarova J; Georgieva S; Rangelov M; Todorova N
    Amino Acids; 2020 Oct; 52(10):1375-1390. PubMed ID: 33011823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the structure-activity relationship in a series of new LVV- and VV-hemorphin-7 analogues designed as potential anticonvulsant agents.
    Todorov P; Georgieva S; Peneva P; Tchekalarova J
    Amino Acids; 2022 Feb; 54(2):261-275. PubMed ID: 34978007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization and anticonvulsant activity of new azobenzene-containing VV-hemorphin-5 bio photoswitch.
    Todorov PT; Peneva PN; Georgieva SI; Tchekalarova J; Vitkova V; Antonova K; Georgiev A
    Amino Acids; 2019 Mar; 51(3):549-563. PubMed ID: 30604096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, molecular docking, electrochemical and fluorimetric analysis of new caffeic and cinnamic acid-conjugated hemorphin derivatives designed as potential anticonvulsant and antinociceptive agents.
    Todorov P; Georgieva S; Peneva P; Nikolov S; Rangelov M; Todorova N; Pechlivanova D; Tchekalarova J
    Bioorg Chem; 2024 Feb; 143():107063. PubMed ID: 38150935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization and nociceptive screening of new VV-hemorphin-5 analogues.
    Todorov P; Peneva P; Pechlivanova D; Georgieva S; Dzhambazova E
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3073-3079. PubMed ID: 30078474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive Effects of VV-Hemorphin-5 Peptide Analogues Containing Amino phosphonate Moiety in Mouse Formalin Model of Pain.
    Assenov B; Pechlivanova D; Dzhambazova E; Peneva P; Todorov P
    Protein Pept Lett; 2021; 28(4):442-449. PubMed ID: 32798365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization, and biological study of new synthetic opioid hemorphin-4 peptides containing sterically restricted nonnatural amino acids.
    Todorov P; Georgieva S; Trapella C; Chakarov K; Tchekalarova J; Pechlivanova D; Cheshmedzhieva D; Fantinati A; Illuminati D
    Arch Pharm (Weinheim); 2024 Jul; 357(7):e2400052. PubMed ID: 38578075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization and evaluation of anti-hyperalgesia, anticonvulsant and antioxidant activity of novel VV-hemorphin-5 analogs.
    Todorov P; Georgieva S; Tchekalarova J; Peneva P; Mateeva P; Assenov B; Dzhambazova E; Pechlivanova D
    Arch Pharm (Weinheim); 2023 Oct; 356(10):e2300267. PubMed ID: 37532631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel fused 1,2,3-triazolo-benzodiazepine derivatives as potent anticonvulsant agents: design, synthesis, in vivo, and in silico evaluations.
    Shafie A; Mohammadi-Khanaposhtani M; Asadi M; Rahimi N; Ranjbar PR; Ghasemi JB; Larijani B; Mahdavi M; Shafaroodi H; Dehpour AR
    Mol Divers; 2020 Feb; 24(1):179-189. PubMed ID: 30895449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioligand binding properties of VV-hemorphin 7, an atypical opioid peptide.
    Szikra J; Benyhe S; Orosz G; Darula Z; Piot JM; Fruitier I; Monory K; Hanoune J; Borsodi A
    Biochem Biophys Res Commun; 2001 Mar; 281(3):670-7. PubMed ID: 11237710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the anticonvulsant effect of novel melatonin derivatives in the intravenous pentylenetetrazol seizure test in mice.
    Tchekalarova J; Angelova VT; Todorova N; Andreeva-Gateva P; Rangelov M
    Eur J Pharmacol; 2019 Nov; 863():172684. PubMed ID: 31545983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and evaluation of anticonvulsant activities of benzoxazole derivatives containing the 1,2,4-triazolone moiety.
    Song MX; Huang Y; Wang S; Wang ZT; Deng XQ
    Arch Pharm (Weinheim); 2019 Aug; 352(8):e1800313. PubMed ID: 31330092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Docking and Anticonvulsant Activity of Newly Synthesized Quinazoline Derivatives.
    Abuelizz HA; Dib RE; Marzouk M; Anouar EH; A Maklad Y; N Attia H; Al-Salahi R
    Molecules; 2017 Jun; 22(7):. PubMed ID: 28665338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, pharmacological evaluation, and docking study of new acridone-based 1,2,4-oxadiazoles as potential anticonvulsant agents.
    Mohammadi-Khanaposhtani M; Shabani M; Faizi M; Aghaei I; Jahani R; Sharafi Z; Shamsaei Zafarghandi N; Mahdavi M; Akbarzadeh T; Emami S; Shafiee A; Foroumadi A
    Eur J Med Chem; 2016 Apr; 112():91-98. PubMed ID: 26890115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excavating precursors from the traditional Chinese herb Polygala tenuifolia and Gastrodia elata: Synthesis, anticonvulsant activity evaluation of 3,4,5-trimethoxycinnamic acid (TMCA) ester derivatives.
    Zhao Z; Bai Y; Xie J; Chen X; He X; Sun Y; Bai Y; Zhang Y; Wu S; Zheng X
    Bioorg Chem; 2019 Jul; 88():102832. PubMed ID: 31102809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of anticonvulsant activities of 7-phenyl-4,5,6,7-tetrahydrothieno[3,2-b ]pyridine derivatives.
    Wang S; Liu H; Wang X; Lei K; Li G; Li X; Wei L; Quan Z
    Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900106. PubMed ID: 31364202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, and Biological Evaluation of 6-(2-Amino-substituted phenyl)-4-(substituted phenyl)-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Anticonvulsant Agents.
    Khan AA; Siddiqui N; Akhtar MJ; Ali Z; Yar MS
    Arch Pharm (Weinheim); 2016 Apr; 349(4):277-92. PubMed ID: 26996080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.